Ras effector switching promotes divergent cell fates in C. elegans vulval patterning

Area of Science:

• Developmental biology
• Cell signaling
• Molecular genetics

Background:

• Epidermal growth factor (EGF) signaling pathways regulate cell fate decisions in development.
• Ras proteins are key signaling molecules, with Raf and RalGEF being known effectors.
• The C. elegans vulva provides a model system for studying cell fate patterning.

Purpose of the Study:

• To elucidate the mechanism by which a spatial epidermal growth factor (EGF) gradient influences cell fate in the C. elegans vulva.
• To identify the downstream effectors of Ras signaling that mediate distinct cell fates (1° and 2°).
• To understand how Ras effector usage is regulated by morphogen gradients during development.

Main Methods:

• Genetic analysis in C. elegans.
• Investigating the roles of Ras, Raf, RalGEF, and Ral in vulval patterning.
• Analyzing the effects of EGF gradients on cell fate determination.

Main Results:

• Ras signaling utilizes both Raf and RalGEF to control vulval cell fates.
• The Ras-Raf pathway promotes primary (1°) vulval fate.
• The Ras-RalGEF-Ral pathway antagonizes 1° fate and promotes secondary (2°) fate, particularly in response to the EGF gradient.

Conclusions:

• A novel Ras effector-switching mechanism dictates cell fate based on positional information within an EGF gradient.
• This mechanism involves switching Ras effector usage from Raf to RalGEF to promote 2° fate over 1° fate.
• Findings offer insights into developmental signaling and potential implications for cancer biology regarding effector dependency.